%0 Journal Article
%A Horne, Hisani N
%A Oh, Hannah
%A Sherman, Mark E
%A Palakal, Maya
%A Hewitt, Stephen M
%A Schmidt, Marjanka K
%A Milne, Roger L
%A Hardisson, David
%A Benitez, Javier
%A Blomqvist, Carl
%A Bolla, Manjeet K
%A Brenner, Hermann
%A Chang-Claude, Jenny
%A Cora, Renata
%A Couch, Fergus J
%A Cuk, Katarina
%A Devilee, Peter
%A Easton, Douglas F
%A Eccles, Diana M
%A Eilber, Ursula
%A Hartikainen, Jaana M
%A Heikkilä, Päivi
%A Holleczek, Bernd
%A Hooning, Maartje J
%A Jones, Michael
%A Keeman, Renske
%A Mannermaa, Arto
%A Martens, John W M
%A Muranen, Taru A
%A Nevanlinna, Heli
%A Olson, Janet E
%A Orr, Nick
%A Perez, Jose I A
%A Pharoah, Paul D P
%A Ruddy, Kathryn J
%A Saum, Kai-Uwe
%A Schoemaker, Minouk J
%A Seynaeve, Caroline
%A Sironen, Reijo
%A Smit, Vincent T H B M
%A Swerdlow, Anthony J
%A Tengström, Maria
%A Thomas, Abigail S
%A Timmermans, A Mieke
%A Tollenaar, Rob A E M
%A Troester, Melissa A
%A van Asperen, Christi J
%A van Deurzen, Carolien H M
%A Van Leeuwen, Flora F
%A Van't Veer, Laura J
%A García-Closas, Montserrat
%A Figueroa, Jonine D
%T E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.
%J Scientific reports
%V 8
%N 1
%@ 2045-2322
%C London
%I Nature Publishing Group
%M DKFZ-2018-00462
%P 6574
%D 2018
%X E-cadherin (CDH1) is a putative tumor suppressor gene implicated in breast carcinogenesis. Yet, whether risk factors or survival differ by E-cadherin tumor expression is unclear. We evaluated E-cadherin tumor immunohistochemistry expression using tissue microarrays of 5,933 female invasive breast cancers from 12 studies from the Breast Cancer Consortium. H-scores were calculated and case-case odds ratios (OR) and 95
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:29700408
%2 pmc:PMC5920115
%R 10.1038/s41598-018-23733-4
%U https://inrepo02.dkfz.de/record/132818